The technology and innovation industry’s rapid growth and unparalleled significance have placed it squarely in the crosshairs of overeager regulators in both the U.S. and Europe. While cloaking their actions as protecting competition, recent moves by these regulators reveal a troubling pattern: a willingness to bypass established laws and norms to advance an increasingly ideological agenda. These misguided actions not only threaten innovations coming out of the technology sector, but we are now seeing the impact it’s having on potential lifesaving technologies in the bio-tech and healthcare sectors too. Unfortunately, this unchecked regulatory overreach will not only undermine innovation and hurt consumers, but it also risks ceding our leadership across a number of industries to China. […]
